Natural Killer Cells: From Bench to Bedside
A special issue of Immuno (ISSN 2673-5601). This special issue belongs to the section "Innate Immunity and Inflammation".
Deadline for manuscript submissions: closed (31 January 2022) | Viewed by 20010
Special Issue Editor
Interests: inflammation; natural killer (NK) cells; immune response; metabolism; vaccines
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Natural Killer (NK) cells were discovered more than five decades ago, and since then the role of these cells in different physiological and pathological responses has been studied extensively. However, more research is required to understand the different responses of NK cells, their subpopulations, their modulation, the importance of a wide variety of receptors, their interaction with several cell types to either promote cell responses or destroy them, and their response to therapies in different diseases. In summary, more information is required to ascertain the role of these cells in the innate immune response and the adaptive immune response. NK cells have been shown to be involved in the tolerogenic response, pregnancy, the anti-tumor response, antiviral responses, transplantation, parasitic diseases, aging, and some other diseases. NK tumors and immunodeficiencies have also been studied. This Special Issue aims to provide a general overview of NK cells, from fundamental science to clinical research, the potential use of these cells in different models, and how therapy may modulate their function. By providing a broad overview of NK cell research, we hope that readers will gain a better understanding of these cells and their role in the immune response. Any contribution on NK cells, independently of the species, is welcome.
Prof. Dr. Juan Bautista De Sanctis
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Immuno is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Cytotoxicity
- Tolerance
- Transplant
- Therapy
- Cancer
- Viral diseases
- Parasitic diseases
- Aging
- Immune deficiency
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.